Overview A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma Status: Recruiting Trial end date: 2025-12-31 Target enrollment: Participant gender: Summary The study is being conducted to evaluate the safety and efficacy of SHR2554 with CHOP/CHOEP in treatment- naïve peripheral T-cell lymphoma. Phase: Phase 1/Phase 2 Details Lead Sponsor: Jiangsu HengRui Medicine Co., Ltd.